Open AccessMore Pronounced Muscle Loss During Immunochemotherapy is Associated with Worse Clinical Outcomes in Newly Diagnosed Patients with Diffuse Large B-Cell Lymphoma with Unfavorable Features
Author(s) -
Marko Lucijanić,
Renata Huzjan Korunić,
Martina Sedinić,
Rajko Kušec,
Vlatko Pejša
Publication year - 2021
Publication title -
therapeutics and clinical risk management
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.719
H-Index - 55
eISSN - 1178-203X
pISSN - 1176-6336
DOI - 10.2147/tcrm.s323749
Subject(s) - medicine , lymphoma , cachexia , regimen , diffuse large b cell lymphoma , multivariate analysis , weight loss , gastroenterology , progressive disease , cancer , oncology , disease , obesity
Cancer-induced cachexia is associated with poor prognosis in patients with non-Hodgkin lymphoma, but it is unknown how and to what extent curable lymphoma treatments affect the musculoskeletal system.